Douglas H. Yamada

1.7k citations
9 papers · 1.0k indexed · 1 hit paper · h-index 8
  • Immunology top 5%
    • Immune Cell Function and Interaction 6
    • Immunotherapy and Immune Responses 3
    • T-cell and B-cell Immunology 3
    • interferon and immune responses 1
  • Virology top 5%
    • HIV Research and Treatment 2
  • Oncology top 10%
    • CAR-T cell therapy research 1
    • HIV/AIDS Research and Interventions 2
    • HIV/AIDS drug development and treatment 2
  • Hepatology top 10%

Douglas H. Yamada

9 papers receiving 1000 citations

Hit Papers

Blockade of Chronic Type I Interferon Signaling to Contro...5482013202620172021100200300400500

Peers

Douglas H. Yamada
Comparison fields: 5 of 73
  • Immunology 721
  • Virology 96
  • Oncology 256
  • Infectious Diseases 169
  • Hepatology 60
Replace Sian Llewellyn‐Lacey with:
Sian Llewellyn‐Lacey United Kingdom
Yanchun Peng China
Smita Ghanekar United States
Maria Suni United States
Heather D. Marshall United States
Marco Frentsch Germany
Kathrin Gibbert Germany
Sven Létourneau Switzerland
Nobuyo Yawata Japan
SangKon Oh United States
Douglas H. Yamada relative to Sian Llewellyn‐Lacey United Kingdom Sian Llewellyn‐Lacey's profile →
Citations per field
00.5×1.5×2.3×
Sian Llewellyn‐Lacey · 1×
Citations per year

Countries citing papers authored by Douglas H. Yamada

Since Specialization
Citations

This map shows the geographic impact of Douglas H. Yamada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas H. Yamada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas H. Yamada more than expected).

Fields of papers citing papers by Douglas H. Yamada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas H. Yamada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas H. Yamada. The network helps show where Douglas H. Yamada may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Douglas H. Yamada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Douglas H. Yamada Line = papers co-authored together Douglas H. Yamada links everyone, so they are left out of the graph.

All Works

9 of 9 papers shown
#Work
1 20225
2 20187
3 2017135
4 201672
5 201551
6 201546
7 201484
8
Blockade of Chronic Type I Interferon Signaling to Control Persistent LCMV Infectionbreakdown →
2013548
9 200968

About Douglas H. Yamada

Douglas H. Yamada is a scholar working on Virology, Immunology, Infectious Diseases, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 9 papers that have together received 1.0k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (6 papers), Immunotherapy and Immune Responses (3 papers), T-cell and B-cell Immunology (3 papers), HIV Research and Treatment (2 papers), HIV/AIDS Research and Interventions (2 papers), HIV/AIDS drug development and treatment (2 papers), interferon and immune responses (1 paper) and CAR-T cell therapy research (1 paper). The work is most often cited by research in Immunology (721 citations), Virology (96 citations), Oncology (256 citations), Infectious Diseases (169 citations) and Hepatology (60 citations). Douglas H. Yamada has collaborated with scholars based in United States, South Africa and Canada. Frequent co-authors include Heidi Elsaesser, David G. Brooks, Elizabeth Wilson, Jonathan Herskovitz, Genhong Cheng, Jane C. Deng, Christopher L. Karp, Bruce J. Aronow, Sujit R. Jangam and David M. Kelso. Their work appears in journals such as Scientific Reports, Journal of Interferon & Cytokine Research, Science, Immunity and Cell Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026